Cargando…

Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE)

INTRODUCTION: This study aimed to verify the association between ovarian cancer (OC) and reproductive‐ and lifestyle‐related risk factors stratified by the subtype of OC. METHODS: In this matched case–control study derived from the Korean epithelial ovarian cancer study (Ko‐EVE), we calculated the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Soseul, Hong, Youjin, Kim, Byoung‐Gie, Choi, Ji‐Yeob, Kim, Jae Weon, Park, Sang‐Yoon, Kim, Jae‐Hoon, Kim, Yong‐man, Lee, Jong‐Min, Kim, Tae Jin, Park, Sue K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134271/ https://www.ncbi.nlm.nih.gov/pubmed/36789760 http://dx.doi.org/10.1002/cam4.5612

Ejemplares similares

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2021)

Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea
por: Park, Boyoung, et al.
Publicado: (2016)

Erratum to: Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea
por: Park, Boyoung, et al.
Publicado: (2016)

Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
por: Paik, E Sun, et al.
Publicado: (2019)

The Effect of Breastfeeding Duration and Parity on the Risk of Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis
por: Sung, Ho Kyung, et al.
Publicado: (2016)

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
por: Lee, Jung-Yun, et al.
Publicado: (2019)

Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes
por: Barnes, Bethany M., et al.
Publicado: (2021)

Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012
por: Kim, Se Ik, et al.
Publicado: (2016)

Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma
por: Kim, Hyun Jin, et al.
Publicado: (2017)

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
por: Lee, Jung-Yun, et al.
Publicado: (2022)

Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
por: Park, Junsik, et al.
Publicado: (2023)

Histologic distribution of borderline ovarian tumors worldwide: a systematic review
por: Song, Taejong, et al.
Publicado: (2013)

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
por: Jang, Ji Yon Agnes, et al.
Publicado: (2017)

Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model
por: Lee, Hwa-Young, et al.
Publicado: (2013)

Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
por: Kim, Yoo-Na, et al.
Publicado: (2023)

Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older
por: Hong, Youjin, et al.
Publicado: (2022)

Thymosin β(10) Expression Driven by the Human TERT Promoter Induces Ovarian Cancer-Specific Apoptosis through ROS Production
por: Kim, Young-Chae, et al.
Publicado: (2012)

Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer
por: Park, Jin-Young, et al.
Publicado: (2016)

The anti-cancer effects of itraconazole in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2017)

Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2019)

Prediction of a high-risk group based on postoperative nadir CA-125 levels in patients with advanced epithelial ovarian cancer
por: Kang, Sokbom, et al.
Publicado: (2011)

Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods
por: Paik, E Sun, et al.
Publicado: (2019)

Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells
por: Choi, Yun-Jung, et al.
Publicado: (2016)

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG)
por: Kim, Miseon, et al.
Publicado: (2018)

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial
por: Park, Junsik, et al.
Publicado: (2021)

The effects of selenium on tumor growth in epithelial ovarian carcinoma
por: Park, Jin Sun, et al.
Publicado: (2012)

Ovarian metastasis from pulmonary adenocarcinoma
por: Jung, Young-Eun, et al.
Publicado: (2013)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
por: Paik, E Sun, et al.
Publicado: (2018)

Clinicopathological aspects of patients with recurrence of borderline ovarian tumors
por: Oh, Sumin, et al.
Publicado: (2015)

Primary ovarian choriocarcinoma mimicking ectopic pregnancy
por: Heo, Eun Jin, et al.
Publicado: (2014)

Differential hRad17 expression by histologic subtype of ovarian cancer
por: Young, Jennifer L, et al.
Publicado: (2011)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Characterization of rare histological subtypes of ovarian cancer based on molecular profiling
por: Takahashi, Nobutaka, et al.
Publicado: (2022)

FIGO staging in ovarian carcinoma and histological subtypes
por: Kehoe, Sean
Publicado: (2020)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qko4ouk90u5h6d7vfmdg4aue3i